US Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals

Watchlist
  • 19.205
  • -0.295-1.51%
Close Feb 26 16:00 ET
  • 18.170
  • -1.035-5.39%
Pre 04:11 ET
6.43BMarket Cap204.31P/E (TTM)

Telix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telix Pharmaceuticals FY2024 Annual Report Date

Currency：USDFeb 19, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
484.08M
487.29M
+3.21M
Beat Est.
+41.46%
+42.40%
+0.66%
EPS
0.12
0.09
-0.03
Miss Est.
--
+720.64%
-25.00%
Analyst Rating
No Data

Telix Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
DatePeriodRevenue/EstimateEarnings Call
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
--------
--------

Unlock Free Earnings Estimates

Telix Pharmaceuticals Earnings Reports

  • 20-F: FY2024 Annual Report

    Feb 24 07:02 ET

    • Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Investment Theme Recent IPOs
    Recent IPOs
    Intraday+0.29%